Evaluation of non-ATP competitive PI3K# inhibition with IOA-244 in the treatment of lymphoma

Research unit

INNOSUISSE

Project number

55179.1 IP-LS

Project title

Evaluation of non-ATP competitive PI3K? inhibition with IOA-244 in the treatment of lymphoma

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	Inhibition of PI3K? is an established modality for the treatment of lymphoma. The proposed project will deliver mechanistic and efficacy information on iOnctura?s PI3K? inhibitor IOA-244, which has a novel mechanism of target inhibition.